Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Cell Reports
|
October 4, 2018
XBP1-KLF9 Axis Acts as a Molecular Rheostat to Control the Transition from Adaptive to Cytotoxic Unfolded Protein Response
Emily E Fink, Sudha Moparthy, Archis Bagati, et al.
Aging
|
December 20, 2012
Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion
Sudha Mannava, Kalyana C Moparthy, Linda J Wheeler, et al.
Cancer Research
|
January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P Singh, Austin R Dosch, Siddharth Mehra, et al.
Iscience
|
November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiation
Kanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Scientific Reports
|
January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
Tatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease
Franca Rosa Guerini, Cristina Agliardi, Manuela Sironi, et al.
JAMA Neurology
|
July 1, 2014
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study)
Marinella Clerico, Irene Schiavetti, Stefania F De Mercanti, et al.
Biomolecules
|
October 29, 2025
Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma
Alexei A Maslov, Nicholas H Trageser, Julia V Kichina, et al.
Gastroenterology
|
August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer
Jashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis
Supriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Cell Reports
|
October 4, 2018
XBP1-KLF9 Axis Acts as a Molecular Rheostat to Control the Transition from Adaptive to Cytotoxic Unfolded Protein Response
Emily E Fink, Sudha Moparthy, Archis Bagati, et al.
Aging
|
December 20, 2012
Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion
Sudha Mannava, Kalyana C Moparthy, Linda J Wheeler, et al.
Cancer Research
|
January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P Singh, Austin R Dosch, Siddharth Mehra, et al.
Iscience
|
November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiation
Kanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Scientific Reports
|
January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
Tatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease
Franca Rosa Guerini, Cristina Agliardi, Manuela Sironi, et al.
JAMA Neurology
|
July 1, 2014
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study)
Marinella Clerico, Irene Schiavetti, Stefania F De Mercanti, et al.
Biomolecules
|
October 29, 2025
Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma
Alexei A Maslov, Nicholas H Trageser, Julia V Kichina, et al.
Gastroenterology
|
August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer
Jashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis
Supriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Page
of 13